Daniel Pharand

Biography

Mr. Pharand is a Chartered accountant with over 25 years of experience in the pharmaceutical, biotech and life sciences industries where he has a proven track record as a portfolio manager. Mr Pharand was the Chief Financial Officer of Pharmacia Canada and of Pharmacia KK (Japan). He subsequently became an entrepreneur with a successful Canadian distribution company of innovative pedicular screws systems in orthopaedic therapies. Mr Pharand later was involved in the Biotech Venture with Innovatech Grand Montreal over his 5 years as Portfolio Manager. Mr Pharand is presently Chief Financial Officer at Cato Research. Mr. Pharand has also acted as a director and has served on various board committees for more than 30 publicly traded or life sciences corporations including Corautus Genetics Inc. (NASDAQ : VEGF), Bio 1 Inc. (now TSX-V : ARU) and LAB International Inc. (TSX : LAB). Mr. Pharand is also a director of Mistral Pharma Inc. (TSX-V: MPI). Mr. Pharand is a Chartered accountant with over 25 years of experience in the pharmaceutical, biotech and life sciences industries where he has a proven track record as a portfolio manager. Mr Pharand was the Chief Financial Officer of Pharmacia Canada and of Pharmacia KK (Japan). He subsequently became an entrepreneur with a successful Canadian distribution company of innovative pedicular screws systems in orthopaedic therapies. Mr Pharand later was involved in the Biotech Venture with Innovatech Grand Montreal over his 5 years as Portfolio Manager. Mr Pharand is presently Chief Financial Officer at Cato Research. Mr. Pharand has also acted as a director and has served on various board committees for more than 30 publicly traded or life sciences corporations including Corautus Genetics Inc. (NASDAQ : VEGF), Bio 1 Inc. (now TSX-V : ARU) and LAB International Inc. (TSX : LAB). Mr. Pharand is also a director of Mistral Pharma Inc. (TSX-V: MPI).

Research Interest

Finance